Sideroblastic anemia natural history, complications and prognosis
Sideroblastic anemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sideroblastic anemia natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Sideroblastic anemia natural history, complications and prognosis |
FDA on Sideroblastic anemia natural history, complications and prognosis |
CDC on Sideroblastic anemia natural history, complications and prognosis |
Sideroblastic anemia natural history, complications and prognosis in the news |
Blogs on Sideroblastic anemia natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Natural History
- Majority of patients of sideroblastic anemia at the time of diagnosis shows erythroid abnormalities and ineffective erythropoiesis,
- Granulocytic and/or megakaryocytic cell lines involvement is also common.
- In the initial stages bone marrow reveal erythroid expansion with ineffective erythropoiesis
- Progression to bone marrow failure occurs in the course of the disease
- The next phase in natural history of sideroblastic anemia is iron overload and evolution to nonlymphocytic leukemia
- The most common causes of death are related to complications of iron overload and evolution into ANLL..[1]
Complications
Common complications of sideroblastic anemia include
- Secondry hemochromatosis
- Thrombocytopenia
- Growth retardation
- Blindness
- Deafness
- Ineffective erythropoiesis
Prognosis
- Depending on the type of sideroblastic anemia the prognosis may vary. However, the prognosis is generally regarded as good[1].
- Sideroblastic anemia secondry to drugs or alcohol as underlying cause is associated with the most favorable prognosis.
- (5-10%) of Severe refractory sideroblastic anemias associated with MDS undergo leukemic transformation.
- AML markedly reduce life expectancy
- Patients who do not need blood transfusions are likely to be long-term survivors.
- The transfusion dependent are at risk of death from the complications of secondary hemochromatosis. .